ABOUT THIS FUND
The fund seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the “Cannabis Business” in the United States, and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology and life sciences industry group. The fund is non-diversified.
PRICE
$0.76 ▲ UP 48.35% (+$73.38)—
No price history available for MJUS over this range.
HOLDINGS
TOP 2 OF 2 · 2.43% OF THE FUNDRANK STOCK WEIGHT SHARES VALUE
